| 1 Primary liver cancer in Japan,Clinicopathologic features and results of surgical treatment liver Cancer Study Group of Japan[J].Ann Surg,1990,211:277-287.
2 Chow NH,Hsu PI,Ling XZ,et al.Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma[J].Human Pathol,1997,28(6): 698-703.
3 Zhou J,Tang ZY,Fan J,et al.Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus[J].J Cancer Res Clin Oncol,2000,126(1):57-61.
4 Llovet JM,Bru C,Bruix J,et al.Prognosis of hepatocellular carcinoma:The BCLC staging classification[J].Semin Liver Dis,1999,19:329-338.
5 Pawarode A.Voravud N,Sriuranpong V,et al.Natural history of untreated primary hepatocellular carcinoma:a retrospective study of 157 patients[J].Am J Clin Oncol, 1998,21:386-391.
6 Lee HS,Kim JS,Choi IJ,et al.The safety and ef ? cacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction.A prospective controlled study[J].Cancer,1997, 79:2087-94.
7 Chun JW,Park JH,Han JK,et al t Hepatocellular carcinoma and portal vein invasion, results of treatment with transcatheter oily chemoembolization[J],AJR, 1995,165:315-321.
8徐爱民,程红岩,陈栋,等.放射介入栓塞化疗对肝癌合并门静脉癌栓治疗疗效的观察[J].中国实用外科杂志,2002,9:530-532.
9 Izaki K,Sugimoto K,Sugimura K,et al.Transcatheter arterialembobzation for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complica- ting hepatocellular carcinoma[J].Radiat Med,2004,22(3):155-162.
10司芩,王轩,马巧珍,等.超声引导经皮门静脉栓塞化疗术在中晚期肝癌合并门静脉癌栓治疗中的应用[J].中华超声影像学杂志,1999,8:151—153.
11 Seo DD,Lee HC,Jang MK,et al.Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume:comparison with transarterial chemoembolization[J],Annals of Surgical Oncology,2007,14(12):3501-09.
12陆正华沈锋.杨家和,等.经皮激光消融治疗肝癌门静脉癌栓[J].中华微创外科杂志,2007,4:331-333.
13林礼务,何以牧,高上达,等.超声介入无水酒精治疗门静脉癌栓的探讨[J].中华超声影像学杂志,2001,10:81-83.
14 Yamamodo K.Nakatsuka A,Tanaka N,et al.Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma[J].J Vasc Interv Radiol,1999,10:641-647.
15 Itamoto T,Nakahara H,Tashiro H,et al.Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombosis of the portal vein[J].J Surg Oncol,2002,80:143-148.
16 Ando E.Tanaka M,Yamashita F,et al.Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis:analysis of 48 cases[J].Cancer,2002,95:588-595.
17 Daichi T,Satoru K,Naondo S,et al.Hepatocellular carcinoma with portal vein tumor thrombosis:clinical characteristics,prognosis,and patient survival analysis [J].Dig Dis Sci,2007.52:3290-95.
18 Liang HL,Yang CF.Pan HB,et al.Percutaneous transsplenic catheterization of the portal venous system[J].Acta Radiol,1997,38:292-295.
19 Yamakado K,Nakatsuka A.Tanaka N,et al.Portal venous stent placement in patients with pancreatic and biliarvneoplasms invading portal veins and causing portal hypertension;initial experience[J].Radiology.2001,220:150-156.
20 Yamakado K,Nakatsuka A,Tanaka N,et al.Malignant portal venous obstructions treated by stent placement:significant factors affecting patency[J].J Vasc Interv Radiol,2001,12:1407-15.
21 Yamakado K,Tanaka N,Nakatsuka A,et al.Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein [J],J Hepatol,1999,30(4):660-668.
22龚高全,王小林,周康荣,等.肝癌伴门静脉癌栓的金属内支架治疗的初步研究[J].临床放射学杂志,2003,22:498-501. |
